Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Market Cap (In BRL)

2.23 Billion

Revenue (In BRL)

1.37 Billion

Net Income (In BRL)

249.8 Million

Avg. Volume

305.27 Thousand

Currency
BRL
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-17.61
PE
-
EPS
-
Beta Value
0.403
ISIN
BRBLAUACNOR8
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Marcelo Rodolfo Hahn
Employee Count
-
Website
https://www.blau.com
Ipo Date
2021-04-19
Details
Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.